Wuhan LinControl Automotive Electronics Co. Ltd. A (688667.SS) stock: key figures, P/E, revenue and dividend
Consumer Discretionary · Automotive Parts & Equipment · China · ISIN CNE1000053R3
Wuhan LinControl Automotive Electronics Co. Ltd. A financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.20 bn CNY | 1.19 bn CNY |
| Gross profit | 207.32 m CNY | 303.60 m CNY |
| Operating income | 8.05 m CNY | 134.80 m CNY |
| EBIT | 9.49 m CNY | 136.00 m CNY |
| Net income | 15.95 m CNY | 134.75 m CNY |
| Diluted EPS – continuing operations | 0.31 CNY | 2.59 CNY |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Wuhan LinControl Automotive Electronics Co. Ltd. A
Wuhan Lincontrol Automotive Electronics Co., Ltd. engages in the development and manufacturing of engine management system and new energy vehicle power electronics control system products in China and internationally. The company offers gasoline direct injection, dual-fuel, motorcycle, and port fuel injection engine management system; double motor, EV/hybrid vehicle, electric machine, and generator controller, as well as EMS hybrid EMS; intelligent vehicle-mounted terminal; and CNG/LNG rail regulator, orifice disk, and injector. It also provides cooperation development service for system functions; matching calibration services; and RDE response services. Wuhan Lincontrol Automotive Electronics Co., Ltd. was founded in 2005 and is based in Wuhan, China.
More stocks
- Champion Iron Ltd (CIA.AX)
- Guangdong Hongjing Optoelectronic Technology Inc. (301479.SZ)
- Jiangxi Black Cat Carbon Black (002068.SZ)
- Kingsgate Consolidated Ltd (KCN.AX)
- Chongqing Pharscin Pharmaceutical Co Ltd (002907.SZ)
- Karoon Energy Ltd (KAR.AX)
- Jutze Intelligent Technology Co Ltd (300802.SZ)
- Myson Century, Inc. (5314.TWO)
- Chongqing Road & Bridge Co Ltd (600106.SS)
- Oxford Biomedica PLC (OXB.L)
- R&G PharmaStudies Co. Ltd. A (301333.SZ)
- OSL Group Ltd (863.HK)
Not investment advice. All data without warranty, price as of 06.11.2026. Details in the risk notice.